The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dry Powder Inhalation Device Market Research Report 2025
Synopsis
Dry powder inhaler (DPI), also known as inhalation powder mist, refers to the solid micronized raw material drug alone or mixed with a suitable carrier, in the form of capsules, vesicles or multi-dose storage, using a specially made dry powder for inhalation A device in which the patient actively inhales aerosolized medication into the lungs. It has decades of research history abroad, and most of the drugs currently on the market are used to treat asthma and chronic obstructive pulmonary disease.
The global Dry Powder Inhalation Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dry Powder Inhalation Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dry Powder Inhalation Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dry Powder Inhalation Device include Merck, ORION CORPORATION, Aptar Pharma, Berry Global, Hovione Technology, Dura Pharmaceuticals, Direct Haler, AstraZeneca and GSK, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dry Powder Inhalation Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Powder Inhalation Device.
Report Scope
The Dry Powder Inhalation Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Powder Inhalation Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dry Powder Inhalation Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
ORION CORPORATION
Aptar Pharma
Berry Global
Hovione Technology
Dura Pharmaceuticals
Direct Haler
AstraZeneca
GSK
Boehringer Ingelheim
3M
Chiesi
Cipla
Mannkind
Mylan
Novartis
Teva
Vectura
Segment by Type
Single Dose
Multiple Doses
Storage Type
Segment by Application
Asthmatic
COPD
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dry Powder Inhalation Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dry Powder Inhalation Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Dry powder inhaler (DPI), also known as inhalation powder mist, refers to the solid micronized raw material drug alone or mixed with a suitable carrier, in the form of capsules, vesicles or multi-dose storage, using a specially made dry powder for inhalation A device in which the patient actively inhales aerosolized medication into the lungs. It has decades of research history abroad, and most of the drugs currently on the market are used to treat asthma and chronic obstructive pulmonary disease.
The global Dry Powder Inhalation Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dry Powder Inhalation Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dry Powder Inhalation Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dry Powder Inhalation Device include Merck, ORION CORPORATION, Aptar Pharma, Berry Global, Hovione Technology, Dura Pharmaceuticals, Direct Haler, AstraZeneca and GSK, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dry Powder Inhalation Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Powder Inhalation Device.
Report Scope
The Dry Powder Inhalation Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Powder Inhalation Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dry Powder Inhalation Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
ORION CORPORATION
Aptar Pharma
Berry Global
Hovione Technology
Dura Pharmaceuticals
Direct Haler
AstraZeneca
GSK
Boehringer Ingelheim
3M
Chiesi
Cipla
Mannkind
Mylan
Novartis
Teva
Vectura
Segment by Type
Single Dose
Multiple Doses
Storage Type
Segment by Application
Asthmatic
COPD
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dry Powder Inhalation Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dry Powder Inhalation Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Dry Powder Inhalation Device Market Overview
1.1 Product Overview and Scope of Dry Powder Inhalation Device
1.2 Dry Powder Inhalation Device Segment by Type
1.2.1 Global Dry Powder Inhalation Device Market Value Comparison by Type (2024-2030)
1.2.2 Single Dose
1.2.3 Multiple Doses
1.2.4 Storage Type
1.3 Dry Powder Inhalation Device Segment by Application
1.3.1 Global Dry Powder Inhalation Device Market Value by Application: (2024-2030)
1.3.2 Asthmatic
1.3.3 COPD
1.3.4 Other
1.4 Global Dry Powder Inhalation Device Market Size Estimates and Forecasts
1.4.1 Global Dry Powder Inhalation Device Revenue 2019-2030
1.4.2 Global Dry Powder Inhalation Device Sales 2019-2030
1.4.3 Global Dry Powder Inhalation Device Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Dry Powder Inhalation Device Market Competition by Manufacturers
2.1 Global Dry Powder Inhalation Device Sales Market Share by Manufacturers (2019-2024)
2.2 Global Dry Powder Inhalation Device Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Dry Powder Inhalation Device Average Price by Manufacturers (2019-2024)
2.4 Global Dry Powder Inhalation Device Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dry Powder Inhalation Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dry Powder Inhalation Device, Product Type & Application
2.7 Dry Powder Inhalation Device Market Competitive Situation and Trends
2.7.1 Dry Powder Inhalation Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dry Powder Inhalation Device Players Market Share by Revenue
2.7.3 Global Dry Powder Inhalation Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dry Powder Inhalation Device Retrospective Market Scenario by Region
3.1 Global Dry Powder Inhalation Device Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Dry Powder Inhalation Device Global Dry Powder Inhalation Device Sales by Region: 2019-2030
3.2.1 Global Dry Powder Inhalation Device Sales by Region: 2019-2024
3.2.2 Global Dry Powder Inhalation Device Sales by Region: 2025-2030
3.3 Global Dry Powder Inhalation Device Global Dry Powder Inhalation Device Revenue by Region: 2019-2030
3.3.1 Global Dry Powder Inhalation Device Revenue by Region: 2019-2024
3.3.2 Global Dry Powder Inhalation Device Revenue by Region: 2025-2030
3.4 North America Dry Powder Inhalation Device Market Facts & Figures by Country
3.4.1 North America Dry Powder Inhalation Device Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Dry Powder Inhalation Device Sales by Country (2019-2030)
3.4.3 North America Dry Powder Inhalation Device Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dry Powder Inhalation Device Market Facts & Figures by Country
3.5.1 Europe Dry Powder Inhalation Device Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Dry Powder Inhalation Device Sales by Country (2019-2030)
3.5.3 Europe Dry Powder Inhalation Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Dry Powder Inhalation Device Market Facts & Figures by Country
3.6.1 Asia Pacific Dry Powder Inhalation Device Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Dry Powder Inhalation Device Sales by Country (2019-2030)
3.6.3 Asia Pacific Dry Powder Inhalation Device Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Dry Powder Inhalation Device Market Facts & Figures by Country
3.7.1 Latin America Dry Powder Inhalation Device Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Dry Powder Inhalation Device Sales by Country (2019-2030)
3.7.3 Latin America Dry Powder Inhalation Device Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Dry Powder Inhalation Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Dry Powder Inhalation Device Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Dry Powder Inhalation Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Dry Powder Inhalation Device Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dry Powder Inhalation Device Sales by Type (2019-2030)
4.1.1 Global Dry Powder Inhalation Device Sales by Type (2019-2024)
4.1.2 Global Dry Powder Inhalation Device Sales by Type (2025-2030)
4.1.3 Global Dry Powder Inhalation Device Sales Market Share by Type (2019-2030)
4.2 Global Dry Powder Inhalation Device Revenue by Type (2019-2030)
4.2.1 Global Dry Powder Inhalation Device Revenue by Type (2019-2024)
4.2.2 Global Dry Powder Inhalation Device Revenue by Type (2025-2030)
4.2.3 Global Dry Powder Inhalation Device Revenue Market Share by Type (2019-2030)
4.3 Global Dry Powder Inhalation Device Price by Type (2019-2030)
5 Segment by Application
5.1 Global Dry Powder Inhalation Device Sales by Application (2019-2030)
5.1.1 Global Dry Powder Inhalation Device Sales by Application (2019-2024)
5.1.2 Global Dry Powder Inhalation Device Sales by Application (2025-2030)
5.1.3 Global Dry Powder Inhalation Device Sales Market Share by Application (2019-2030)
5.2 Global Dry Powder Inhalation Device Revenue by Application (2019-2030)
5.2.1 Global Dry Powder Inhalation Device Revenue by Application (2019-2024)
5.2.2 Global Dry Powder Inhalation Device Revenue by Application (2025-2030)
5.2.3 Global Dry Powder Inhalation Device Revenue Market Share by Application (2019-2030)
5.3 Global Dry Powder Inhalation Device Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Dry Powder Inhalation Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Dry Powder Inhalation Device Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 ORION CORPORATION
6.2.1 ORION CORPORATION Corporation Information
6.2.2 ORION CORPORATION Description and Business Overview
6.2.3 ORION CORPORATION Dry Powder Inhalation Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 ORION CORPORATION Dry Powder Inhalation Device Product Portfolio
6.2.5 ORION CORPORATION Recent Developments/Updates
6.3 Aptar Pharma
6.3.1 Aptar Pharma Corporation Information
6.3.2 Aptar Pharma Description and Business Overview
6.3.3 Aptar Pharma Dry Powder Inhalation Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Aptar Pharma Dry Powder Inhalation Device Product Portfolio
6.3.5 Aptar Pharma Recent Developments/Updates
6.4 Berry Global
6.4.1 Berry Global Corporation Information
6.4.2 Berry Global Description and Business Overview
6.4.3 Berry Global Dry Powder Inhalation Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Berry Global Dry Powder Inhalation Device Product Portfolio
6.4.5 Berry Global Recent Developments/Updates
6.5 Hovione Technology
6.5.1 Hovione Technology Corporation Information
6.5.2 Hovione Technology Description and Business Overview
6.5.3 Hovione Technology Dry Powder Inhalation Device Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hovione Technology Dry Powder Inhalation Device Product Portfolio
6.5.5 Hovione Technology Recent Developments/Updates
6.6 Dura Pharmaceuticals
6.6.1 Dura Pharmaceuticals Corporation Information
6.6.2 Dura Pharmaceuticals Description and Business Overview
6.6.3 Dura Pharmaceuticals Dry Powder Inhalation Device Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Dura Pharmaceuticals Dry Powder Inhalation Device Product Portfolio
6.6.5 Dura Pharmaceuticals Recent Developments/Updates
6.7 Direct Haler
6.6.1 Direct Haler Corporation Information
6.6.2 Direct Haler Description and Business Overview
6.6.3 Direct Haler Dry Powder Inhalation Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Direct Haler Dry Powder Inhalation Device Product Portfolio
6.7.5 Direct Haler Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Corporation Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Dry Powder Inhalation Device Sales, Revenue and Gross Margin (2019-2024)
6.8.4 AstraZeneca Dry Powder Inhalation Device Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 GSK
6.9.1 GSK Corporation Information
6.9.2 GSK Description and Business Overview
6.9.3 GSK Dry Powder Inhalation Device Sales, Revenue and Gross Margin (2019-2024)
6.9.4 GSK Dry Powder Inhalation Device Product Portfolio
6.9.5 GSK Recent Developments/Updates
6.10 Boehringer Ingelheim
6.10.1 Boehringer Ingelheim Corporation Information
6.10.2 Boehringer Ingelheim Description and Business Overview
6.10.3 Boehringer Ingelheim Dry Powder Inhalation Device Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Boehringer Ingelheim Dry Powder Inhalation Device Product Portfolio
6.10.5 Boehringer Ingelheim Recent Developments/Updates
6.11 3M
6.11.1 3M Corporation Information
6.11.2 3M Dry Powder Inhalation Device Description and Business Overview
6.11.3 3M Dry Powder Inhalation Device Sales, Revenue and Gross Margin (2019-2024)
6.11.4 3M Dry Powder Inhalation Device Product Portfolio
6.11.5 3M Recent Developments/Updates
6.12 Chiesi
6.12.1 Chiesi Corporation Information
6.12.2 Chiesi Dry Powder Inhalation Device Description and Business Overview
6.12.3 Chiesi Dry Powder Inhalation Device Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Chiesi Dry Powder Inhalation Device Product Portfolio
6.12.5 Chiesi Recent Developments/Updates
6.13 Cipla
6.13.1 Cipla Corporation Information
6.13.2 Cipla Dry Powder Inhalation Device Description and Business Overview
6.13.3 Cipla Dry Powder Inhalation Device Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Cipla Dry Powder Inhalation Device Product Portfolio
6.13.5 Cipla Recent Developments/Updates
6.14 Mannkind
6.14.1 Mannkind Corporation Information
6.14.2 Mannkind Dry Powder Inhalation Device Description and Business Overview
6.14.3 Mannkind Dry Powder Inhalation Device Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Mannkind Dry Powder Inhalation Device Product Portfolio
6.14.5 Mannkind Recent Developments/Updates
6.15 Mylan
6.15.1 Mylan Corporation Information
6.15.2 Mylan Dry Powder Inhalation Device Description and Business Overview
6.15.3 Mylan Dry Powder Inhalation Device Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Mylan Dry Powder Inhalation Device Product Portfolio
6.15.5 Mylan Recent Developments/Updates
6.16 Novartis
6.16.1 Novartis Corporation Information
6.16.2 Novartis Dry Powder Inhalation Device Description and Business Overview
6.16.3 Novartis Dry Powder Inhalation Device Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Novartis Dry Powder Inhalation Device Product Portfolio
6.16.5 Novartis Recent Developments/Updates
6.17 Teva
6.17.1 Teva Corporation Information
6.17.2 Teva Dry Powder Inhalation Device Description and Business Overview
6.17.3 Teva Dry Powder Inhalation Device Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Teva Dry Powder Inhalation Device Product Portfolio
6.17.5 Teva Recent Developments/Updates
6.18 Vectura
6.18.1 Vectura Corporation Information
6.18.2 Vectura Dry Powder Inhalation Device Description and Business Overview
6.18.3 Vectura Dry Powder Inhalation Device Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Vectura Dry Powder Inhalation Device Product Portfolio
6.18.5 Vectura Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dry Powder Inhalation Device Industry Chain Analysis
7.2 Dry Powder Inhalation Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dry Powder Inhalation Device Production Mode & Process
7.4 Dry Powder Inhalation Device Sales and Marketing
7.4.1 Dry Powder Inhalation Device Sales Channels
7.4.2 Dry Powder Inhalation Device Distributors
7.5 Dry Powder Inhalation Device Customers
8 Dry Powder Inhalation Device Market Dynamics
8.1 Dry Powder Inhalation Device Industry Trends
8.2 Dry Powder Inhalation Device Market Drivers
8.3 Dry Powder Inhalation Device Market Challenges
8.4 Dry Powder Inhalation Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Dry Powder Inhalation Device Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Dry Powder Inhalation Device Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Dry Powder Inhalation Device Market Competitive Situation by Manufacturers in 2023
Table 4. Global Dry Powder Inhalation Device Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Dry Powder Inhalation Device Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Dry Powder Inhalation Device Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Dry Powder Inhalation Device Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Dry Powder Inhalation Device Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Dry Powder Inhalation Device, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Dry Powder Inhalation Device, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Dry Powder Inhalation Device, Product Type & Application
Table 12. Global Key Manufacturers of Dry Powder Inhalation Device, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dry Powder Inhalation Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Powder Inhalation Device as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Dry Powder Inhalation Device Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Dry Powder Inhalation Device Sales by Region (2019-2024) & (K Units)
Table 18. Global Dry Powder Inhalation Device Sales Market Share by Region (2019-2024)
Table 19. Global Dry Powder Inhalation Device Sales by Region (2025-2030) & (K Units)
Table 20. Global Dry Powder Inhalation Device Sales Market Share by Region (2025-2030)
Table 21. Global Dry Powder Inhalation Device Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Dry Powder Inhalation Device Revenue Market Share by Region (2019-2024)
Table 23. Global Dry Powder Inhalation Device Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Dry Powder Inhalation Device Revenue Market Share by Region (2025-2030)
Table 25. North America Dry Powder Inhalation Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Dry Powder Inhalation Device Sales by Country (2019-2024) & (K Units)
Table 27. North America Dry Powder Inhalation Device Sales by Country (2025-2030) & (K Units)
Table 28. North America Dry Powder Inhalation Device Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Dry Powder Inhalation Device Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Dry Powder Inhalation Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Dry Powder Inhalation Device Sales by Country (2019-2024) & (K Units)
Table 32. Europe Dry Powder Inhalation Device Sales by Country (2025-2030) & (K Units)
Table 33. Europe Dry Powder Inhalation Device Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Dry Powder Inhalation Device Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Dry Powder Inhalation Device Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Dry Powder Inhalation Device Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Dry Powder Inhalation Device Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Dry Powder Inhalation Device Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Dry Powder Inhalation Device Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Dry Powder Inhalation Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Dry Powder Inhalation Device Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Dry Powder Inhalation Device Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Dry Powder Inhalation Device Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Dry Powder Inhalation Device Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Dry Powder Inhalation Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Dry Powder Inhalation Device Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Dry Powder Inhalation Device Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Dry Powder Inhalation Device Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Dry Powder Inhalation Device Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Dry Powder Inhalation Device Sales (K Units) by Type (2019-2024)
Table 51. Global Dry Powder Inhalation Device Sales (K Units) by Type (2025-2030)
Table 52. Global Dry Powder Inhalation Device Sales Market Share by Type (2019-2024)
Table 53. Global Dry Powder Inhalation Device Sales Market Share by Type (2025-2030)
Table 54. Global Dry Powder Inhalation Device Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Dry Powder Inhalation Device Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Dry Powder Inhalation Device Revenue Market Share by Type (2019-2024)
Table 57. Global Dry Powder Inhalation Device Revenue Market Share by Type (2025-2030)
Table 58. Global Dry Powder Inhalation Device Price (US$/Unit) by Type (2019-2024)
Table 59. Global Dry Powder Inhalation Device Price (US$/Unit) by Type (2025-2030)
Table 60. Global Dry Powder Inhalation Device Sales (K Units) by Application (2019-2024)
Table 61. Global Dry Powder Inhalation Device Sales (K Units) by Application (2025-2030)
Table 62. Global Dry Powder Inhalation Device Sales Market Share by Application (2019-2024)
Table 63. Global Dry Powder Inhalation Device Sales Market Share by Application (2025-2030)
Table 64. Global Dry Powder Inhalation Device Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Dry Powder Inhalation Device Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Dry Powder Inhalation Device Revenue Market Share by Application (2019-2024)
Table 67. Global Dry Powder Inhalation Device Revenue Market Share by Application (2025-2030)
Table 68. Global Dry Powder Inhalation Device Price (US$/Unit) by Application (2019-2024)
Table 69. Global Dry Powder Inhalation Device Price (US$/Unit) by Application (2025-2030)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Dry Powder Inhalation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Merck Dry Powder Inhalation Device Product
Table 74. Merck Recent Developments/Updates
Table 75. ORION CORPORATION Corporation Information
Table 76. ORION CORPORATION Description and Business Overview
Table 77. ORION CORPORATION Dry Powder Inhalation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. ORION CORPORATION Dry Powder Inhalation Device Product
Table 79. ORION CORPORATION Recent Developments/Updates
Table 80. Aptar Pharma Corporation Information
Table 81. Aptar Pharma Description and Business Overview
Table 82. Aptar Pharma Dry Powder Inhalation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Aptar Pharma Dry Powder Inhalation Device Product
Table 84. Aptar Pharma Recent Developments/Updates
Table 85. Berry Global Corporation Information
Table 86. Berry Global Description and Business Overview
Table 87. Berry Global Dry Powder Inhalation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Berry Global Dry Powder Inhalation Device Product
Table 89. Berry Global Recent Developments/Updates
Table 90. Hovione Technology Corporation Information
Table 91. Hovione Technology Description and Business Overview
Table 92. Hovione Technology Dry Powder Inhalation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Hovione Technology Dry Powder Inhalation Device Product
Table 94. Hovione Technology Recent Developments/Updates
Table 95. Dura Pharmaceuticals Corporation Information
Table 96. Dura Pharmaceuticals Description and Business Overview
Table 97. Dura Pharmaceuticals Dry Powder Inhalation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Dura Pharmaceuticals Dry Powder Inhalation Device Product
Table 99. Dura Pharmaceuticals Recent Developments/Updates
Table 100. Direct Haler Corporation Information
Table 101. Direct Haler Description and Business Overview
Table 102. Direct Haler Dry Powder Inhalation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Direct Haler Dry Powder Inhalation Device Product
Table 104. Direct Haler Recent Developments/Updates
Table 105. AstraZeneca Corporation Information
Table 106. AstraZeneca Description and Business Overview
Table 107. AstraZeneca Dry Powder Inhalation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. AstraZeneca Dry Powder Inhalation Device Product
Table 109. AstraZeneca Recent Developments/Updates
Table 110. GSK Corporation Information
Table 111. GSK Description and Business Overview
Table 112. GSK Dry Powder Inhalation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. GSK Dry Powder Inhalation Device Product
Table 114. GSK Recent Developments/Updates
Table 115. Boehringer Ingelheim Corporation Information
Table 116. Boehringer Ingelheim Description and Business Overview
Table 117. Boehringer Ingelheim Dry Powder Inhalation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Boehringer Ingelheim Dry Powder Inhalation Device Product
Table 119. Boehringer Ingelheim Recent Developments/Updates
Table 120. 3M Corporation Information
Table 121. 3M Description and Business Overview
Table 122. 3M Dry Powder Inhalation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. 3M Dry Powder Inhalation Device Product
Table 124. 3M Recent Developments/Updates
Table 125. Chiesi Corporation Information
Table 126. Chiesi Description and Business Overview
Table 127. Chiesi Dry Powder Inhalation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Chiesi Dry Powder Inhalation Device Product
Table 129. Chiesi Recent Developments/Updates
Table 130. Cipla Corporation Information
Table 131. Cipla Description and Business Overview
Table 132. Cipla Dry Powder Inhalation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Cipla Dry Powder Inhalation Device Product
Table 134. Cipla Recent Developments/Updates
Table 135. Mannkind Corporation Information
Table 136. Mannkind Description and Business Overview
Table 137. Mannkind Dry Powder Inhalation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Mannkind Dry Powder Inhalation Device Product
Table 139. Mannkind Recent Developments/Updates
Table 140. Mylan Corporation Information
Table 141. Mylan Description and Business Overview
Table 142. Mylan Dry Powder Inhalation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Mylan Dry Powder Inhalation Device Product
Table 144. Mylan Recent Developments/Updates
Table 145. Novartis Corporation Information
Table 146. Novartis Description and Business Overview
Table 147. Novartis Dry Powder Inhalation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Novartis Dry Powder Inhalation Device Product
Table 149. Novartis Recent Developments/Updates
Table 150. Teva Corporation Information
Table 151. Teva Description and Business Overview
Table 152. Teva Dry Powder Inhalation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Teva Dry Powder Inhalation Device Product
Table 154. Teva Recent Developments/Updates
Table 155. Vectura Corporation Information
Table 156. Vectura Description and Business Overview
Table 157. Vectura Dry Powder Inhalation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Vectura Dry Powder Inhalation Device Product
Table 159. Vectura Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Dry Powder Inhalation Device Distributors List
Table 163. Dry Powder Inhalation Device Customers List
Table 164. Dry Powder Inhalation Device Market Trends
Table 165. Dry Powder Inhalation Device Market Drivers
Table 166. Dry Powder Inhalation Device Market Challenges
Table 167. Dry Powder Inhalation Device Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Dry Powder Inhalation Device
Figure 2. Global Dry Powder Inhalation Device Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Dry Powder Inhalation Device Market Share by Type in 2023 & 2030
Figure 4. Single Dose Product Picture
Figure 5. Multiple Doses Product Picture
Figure 6. Storage Type Product Picture
Figure 7. Global Dry Powder Inhalation Device Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Dry Powder Inhalation Device Market Share by Application in 2023 & 2030
Figure 9. Asthmatic
Figure 10. COPD
Figure 11. Other
Figure 12. Global Dry Powder Inhalation Device Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Dry Powder Inhalation Device Market Size (2019-2030) & (US$ Million)
Figure 14. Global Dry Powder Inhalation Device Sales (2019-2030) & (K Units)
Figure 15. Global Dry Powder Inhalation Device Average Price (US$/Unit) & (2019-2030)
Figure 16. Dry Powder Inhalation Device Report Years Considered
Figure 17. Dry Powder Inhalation Device Sales Share by Manufacturers in 2023
Figure 18. Global Dry Powder Inhalation Device Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Dry Powder Inhalation Device Players: Market Share by Revenue in 2023
Figure 20. Dry Powder Inhalation Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Dry Powder Inhalation Device Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Dry Powder Inhalation Device Sales Market Share by Country (2019-2030)
Figure 23. North America Dry Powder Inhalation Device Revenue Market Share by Country (2019-2030)
Figure 24. United States Dry Powder Inhalation Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Dry Powder Inhalation Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Dry Powder Inhalation Device Sales Market Share by Country (2019-2030)
Figure 27. Europe Dry Powder Inhalation Device Revenue Market Share by Country (2019-2030)
Figure 28. Germany Dry Powder Inhalation Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Dry Powder Inhalation Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Dry Powder Inhalation Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Dry Powder Inhalation Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Netherlands Dry Powder Inhalation Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Dry Powder Inhalation Device Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Dry Powder Inhalation Device Revenue Market Share by Region (2019-2030)
Figure 35. China Dry Powder Inhalation Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Dry Powder Inhalation Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Dry Powder Inhalation Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Dry Powder Inhalation Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Dry Powder Inhalation Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Dry Powder Inhalation Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Dry Powder Inhalation Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Dry Powder Inhalation Device Sales Market Share by Country (2019-2030)
Figure 43. Latin America Dry Powder Inhalation Device Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Dry Powder Inhalation Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Dry Powder Inhalation Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Dry Powder Inhalation Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Colombia Dry Powder Inhalation Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Dry Powder Inhalation Device Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Dry Powder Inhalation Device Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Dry Powder Inhalation Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Dry Powder Inhalation Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Dry Powder Inhalation Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Dry Powder Inhalation Device by Type (2019-2030)
Figure 54. Global Revenue Market Share of Dry Powder Inhalation Device by Type (2019-2030)
Figure 55. Global Dry Powder Inhalation Device Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Dry Powder Inhalation Device by Application (2019-2030)
Figure 57. Global Revenue Market Share of Dry Powder Inhalation Device by Application (2019-2030)
Figure 58. Global Dry Powder Inhalation Device Price (US$/Unit) by Application (2019-2030)
Figure 59. Dry Powder Inhalation Device Value Chain
Figure 60. Dry Powder Inhalation Device Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Industrial Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
